Long non-coding RNA LINC-PINT is associated with favorable prognosis in cancer patients: a meta-analysis

Author:

Koh Hyun Min1,Hyun Chang Lim1,Lee Dong Hui2,Park Sungjoon2,Han Nayoung3

Affiliation:

1. Jeju National University School of Medicine

2. Jeju National University Hospital

3. Jeju National University

Abstract

Abstract Background There is growing evidence that long non-coding RNA long iatrogenic non-protein-coding RNA p53-induced transcript (LINC-PINT) is highly expressed in cancer tissue and is associated with the prognosis of cancer patients. The present study systematically analyzed the prognostic significance of LINC-PINT expression in cancer patients. Methods We collected eligible studies through the PubMed, Embase, and Cochrane library searches until February 1, 2024. The prognostic significance of LINC-PINT expression was evaluated by conducting a meta-analysis. Results Eleven eligible studies with 2876 cancer patients were collected. The pooled results revealed that LINC-PINT expression was associated with favorable overall survival (OS) and disease-free survival (DFS) in cancer patients (for OS, hazard ratio [HR] 0.72, 95% confidence interval [CI] 0.64–0.80, p < 0.001; for DFS, HR 0.70, 95% CI 0.60–0.82, p < 0.001). Conclusion LINC-PINT expression was associated with favorable OS and DFS, and it may serve as a valuable prognostic marker in cancer patients.

Publisher

Research Square Platform LLC

Reference18 articles.

1. The prognostic value of long non-coding RNA H19 in various cancers: a meta-analysis based on 15 studies with 1584 patients and the Cancer Genome Atlas data;Yu H;Medicine,2020

2. The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis;Dong B;BMC Cancer,2019

3. The multidimensional mechanisms of long noncoding RNA function;Marchese FP;Genome Biol,2017

4. Long non-coding RNAs: insights into functions;Mercer TR;Nat Rev Genet,2009

5. Long noncoding RNA: an emerging paradigm of cancer research;Qiu M;Tumor Biol,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3